U.S. NIH halts trial testing COVID-19 blood plasma

Health News
FILE PHOTO: A health worker takes test tubes with plasma and blood samples after a separation process in a centrifuge during a coronavirus disease (COVID-19) vaccination study at the Research Centers of America, in Hollywood, Florida, U.S., September 24, 2020. REUTERS/Marco Bello

(Reuters) – The U.S. National Institutes of Health (NIH) said on Tuesday it had halted a trial testing convalescent blood plasma in treatment of patients with mild to moderate COVID-19 symptoms.

The NIH said an independent data monitoring board found that the plasma was unlikely to benefit this group of patients. (bit.ly/3rbOIdh)

Source: Read Full Article

Related posts:
  1. Pfizer study another worry for South Africa's vaccine rollout
  2. GSK and Sanofi start with new COVID-19 vaccine study after setback
  3. Inovio developing vaccines to target coronavirus variants